Imaging Characteristics of Choroid Plexuses in Presymptomatic Multiple Sclerosis
A Retrospective Study
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received February 12, 2022
- Accepted in final form July 18, 2022
- First Published October 13, 2022.
Author Disclosures
- Vito A.G. Ricigliano, MD, PhD,
- Céline Louapre, MD, PhD,
- Emilie Poirion, PhD,
- Annalisa Colombi, MD,
- Arya Yazdan Panah, MSc,
- Andrea Lazzarotto, MD,
- Emanuele Morena, MD,
- Elodie Martin, PhD,
- Michel Bottlaender, MD, PhD,
- Benedetta Bodini, MD, PhD,
- Danielle Seilhean, MD and
- Bruno Stankoff, MD, PhD
- Vito A.G. Ricigliano, MD, PhD,
Serving on a scientific advisory board for Biogen
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Céline Louapre, MD, PhD,
None
NONE
(1) Biogen, (2) Novartis, (3) Teva, (4) Roche, (5) Merck, (6) Sanofi
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Fellowship from ARSEP foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Emilie Poirion, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Annalisa Colombi, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Arya Yazdan Panah, MSc,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Andrea Lazzarotto, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Emanuele Morena, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Elodie Martin, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Michel Bottlaender, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Benedetta Bodini, MD, PhD,
1) Genzyme, scientific advisory board
NONE
(1) Novartis, speaker honoraria, (2) Biogen, speaker honoraria, (3) Genzyme, speaker honoraria
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Biogen, research support
NONE
NONE
ARSEP postdoctoral research fellowship ARSEP grant 2015, FISM research grant 2018
NONE
NONE
NONE
NONE
NONE
NONE
- Danielle Seilhean, MD and
None
NONE
None
Free neuropathology, member of the editorial board, Patents: A NOVEL ORTHOBUNYAVIRUS IN HUMAN ENCEPHALITIS AND ITS DIAGNOSTIC AND THERAPEUTIC APPLICATONS. EP Appln. 19305604.1 on May 10, 2019, International Appln. PCT/EP2020/062775 on May 7, 2020, and the U.S. Natl. Stage of the PCT application (U.S. Appln. No. 17/606,554)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
ANR COVID-NeuroResp Impact of COVID-19 on the neurophysiology of respiration in COVID-19 patients and a mouse model : 20 KE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Bruno Stankoff, MD, PhD
scientific advisory boards for Novartis, Sanofi
NONE
Lectures for Biogen, Sanofi, Novartis, Merck, Janssen
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Research grants from Merck Serono, Sanofi-Genzyme and Roche
NONE
Grants from Fondation ARSEP, fondation pour la recherche medicale (FRM), DGOS-APHP, PMSA, ANR, INSERM, ICM
None
NONE
NONE
NONE
NONE
NONE
NONE
- From the Sorbonne Université (V.A.G.R., C.L., E.P., A.C., A.Y.P., A.L., Emanuele Morena, Elodie Martin, B.B., D.S., B.S.), Paris Brain Institute, ICM, CNRS, Inserm; Neurology Department (V.A.G.R., A.L., B.B., B.S.), St Antoine Hospital, APHP-Sorbonne, Paris; Neurology Department (C.L.), Pitié-Salpêtrière Hospital, APHP-Sorbonne, Paris; Service D'Imagerie Médicale (E.P.), Hôpital Fondation Adolphe de Rothschild, Paris; Université Paris-Saclay (M.B.), CEA, CNRS, Inserm, BioMaps, Service Hospitalier Frédéric Joliot, Orsay; and Neuropathology Department (D.S.), Pitié-Salpêtrière Hospital, APHP-Sorbonne, Paris, France.
- Correspondence
Prof. Dr. Stankoff bruno.stankoff{at}aphp.fr
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Ann Yeh and Dr. Daniela Castillo Villagrán
► Watch
Related Articles
- No related articles found.